Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Medeon Biodesign, Inc. (6499) Financial Statements

Medeon Biodesign, Inc. Financial Overview

Medeon Biodesign, Inc.'s market cap is currently NT$7.33B. The company's EPS TTM is NT$-7.16; its P/E ratio is -16.44; and it has a dividend yield of 1.03%. Medeon Biodesign, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 419.43MNT$ 292.81MNT$ 196.26MNT$ 298.32MNT$ 68.96M
Gross ProfitNT$ 58.83MNT$ 83.41MNT$ -65.20MNT$ 186.81MNT$ 28.63M
Operating IncomeNT$ -722.51MNT$ -872.20MNT$ -838.99MNT$ -487.84MNT$ -512.88M
EBITDANT$ -615.15MNT$ -754.42MNT$ -1.14BNT$ -370.10MNT$ -453.87M
Net IncomeNT$ -668.06MNT$ -805.51MNT$ -1.20BNT$ -433.76MNT$ 2.08B
Balance Sheet
Cash & Short-Term InvestmentsNT$ 1.22BNT$ 1.21BNT$ 2.14BNT$ 1.55BNT$ 2.35B
Total AssetsNT$ 1.78BNT$ 1.88BNT$ 2.75BNT$ 4.04BNT$ 4.36B
Total DebtNT$ 113.05MNT$ 168.40MNT$ 186.74MNT$ 198.91MNT$ 30.24M
Net DebtNT$ -407.74MNT$ -344.98MNT$ -1.05BNT$ -284.99MNT$ -705.08M
Total LiabilitiesNT$ 243.03MNT$ 341.84MNT$ 375.65MNT$ 376.48MNT$ 176.00M
Stockholders' EquityNT$ 1.48BNT$ 1.52BNT$ 2.32BNT$ 3.60BNT$ 4.13B
Cash Flow
Free Cash FlowNT$ -645.56MNT$ -907.44MNT$ -810.36MNT$ -602.06MNT$ -302.39M
Operating Cash FlowNT$ -629.09MNT$ -832.66MNT$ -755.08MNT$ -461.34MNT$ -293.38M
Investing Cash FlowNT$ 272.56MNT$ 135.21MNT$ 1.60BNT$ 263.44MNT$ -90.64M
Financing Cash FlowNT$ 373.88MNT$ -46.68MNT$ -90.57MNT$ -101.16MNT$ -3.90M

Currency in TWD

Medeon Biodesign, Inc. Earnings and Revenue History

-1.5B01.5B3B-2000 %0 %2000 %4000 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Medeon Biodesign, Inc. Liabilities to Assets

02B4B6B0 %8 %16 %24 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Medeon Biodesign, Inc. Cash Flow

-1B-500M0500M1B1.5B2B2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Medeon Biodesign, Inc. Forecast EPS vs Actual EPS

-3-2-1012Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss
Earnings >